Equities

Haleon PLC

HLN:LSE

Haleon PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)328.60
  • Today's Change-2.40 / -0.73%
  • Shares traded18.08m
  • 1 Year change-6.91%
  • Beta--
Data delayed at least 20 minutes, as of May 02 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

  • Revenue in GBP (TTM)11.24bn
  • Net income in GBP1.08bn
  • Incorporated2021
  • Employees24.00k
  • Location
    Haleon PLCBuilding 5, First Floor, The HeightsBRENTFORD KT13 0NYUnited KingdomGBR
  • Phone+44 19 3282 2000
  • Websitehttps://www.haleon.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
argenx SE980.03m-235.80m17.86bn1.15k17.86bn1.15k
UCB SA4.49bn293.55m20.73bn9.08k20.73bn9.08k
Bayer AG40.77bn-2.52bn23.00bn99.72k23.00bn99.72k
HALEON PLC11.24bn1.08bn30.23bn24.00k30.23bn24.00k
Lonza Group AG5.89bn573.01m33.30bn18.00k33.30bn18.00k
Data as of May 02 2024. Currency figures normalised to Haleon PLC's reporting currency: UK Pound GBX

Institutional shareholders

12.60%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 01 Apr 2024163.50m1.79%
Dodge & Coxas of 01 Apr 2024158.25m1.73%
Norges Bank Investment Managementas of 01 Apr 2024148.00m1.62%
First Eagle Investment Management LLCas of 29 Feb 2024117.21m1.28%
BlackRock Fund Advisorsas of 04 Apr 2024107.65m1.18%
MFS International (UK) Ltd.as of 01 Apr 202498.50m1.08%
GIC Pte Ltd. (Investment Management)as of 01 Apr 202495.44m1.05%
BlackRock Advisors (UK) Ltd.as of 01 Apr 202490.98m1.00%
Franklin Mutual Advisers LLCas of 29 Mar 202485.68m0.94%
Harding Loevner LPas of 28 Mar 202485.40m0.94%
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.